Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR

By Kohashi Kenichi   Oda Yoshinao   Yamamoto Hidetaka   Tamiya Sadafumi   Izumi Teiyu   Ohta Shigeru   Taguchi Tomoaki   Suita Sachiyo   Tsuneyoshi Masazumi  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 817-824

Springer Publishing Company

Access to resources Recommend Favorite

A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells

By Bektas Meryem   Johnson Stewart   Poe William   Bigner Darell   Friedman Henry  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 1053-1058

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas

By Salehi Fateme  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 647-657

Springer Publishing Company

Access to resources Recommend Favorite

Selective Lymphopenia and Opportunistic Infections in Neuroendocrine Tumor Patients Receiving Temozolomide

By Schwarzberg Abraham B.   Stover Elizabeth H.   Sengupta Tanya   Michelini Ann   Vincitore Michele   Baden Lindsey R.   Kulke Matthew H.  

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 249-255

Informa Healthcare

Access to resources Recommend Favorite

Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression

By            

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2313-2322

Spandidos Publications

Access to resources Recommend Favorite